Logo image of CSL

CARLISLE COS INC (CSL) Stock Fundamental Analysis

NYSE:CSL - New York Stock Exchange, Inc. - US1423391002 - Common Stock - Currency: USD

351.13  -25.18 (-6.69%)

Fundamental Rating

6

CSL gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 40 industry peers in the Building Products industry. CSL has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. CSL has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

In the past year CSL was profitable.
CSL had a positive operating cash flow in the past year.
CSL had positive earnings in 4 of the past 5 years.
Of the past 5 years CSL 4 years had a positive operating cash flow.
CSL Yearly Net Income VS EBIT VS OCF VS FCFCSL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

1.2 Ratios

CSL has a Return On Assets of 20.87%. This is amongst the best in the industry. CSL outperforms 97.50% of its industry peers.
With an excellent Return On Equity value of 48.93%, CSL belongs to the best of the industry, outperforming 95.00% of the companies in the same industry.
With a decent Return On Invested Capital value of 16.65%, CSL is doing good in the industry, outperforming 77.50% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CSL is in line with the industry average of 13.18%.
The 3 year average ROIC (12.27%) for CSL is below the current ROIC(16.65%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 20.87%
ROE 48.93%
ROIC 16.65%
ROA(3y)10.04%
ROA(5y)8.83%
ROE(3y)24.51%
ROE(5y)20.79%
ROIC(3y)12.27%
ROIC(5y)11.04%
CSL Yearly ROA, ROE, ROICCSL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30

1.3 Margins

With an excellent Profit Margin value of 26.99%, CSL belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Profit Margin of CSL has grown nicely.
The Operating Margin of CSL (23.42%) is better than 92.50% of its industry peers.
CSL's Operating Margin has improved in the last couple of years.
CSL has a better Gross Margin (37.98%) than 65.00% of its industry peers.
In the last couple of years the Gross Margin of CSL has grown nicely.
Industry RankSector Rank
OM 23.42%
PM (TTM) 26.99%
GM 37.98%
OM growth 3Y21.42%
OM growth 5Y13.53%
PM growth 3Y30.48%
PM growth 5Y4.18%
GM growth 3Y8.16%
GM growth 5Y6.32%
CSL Yearly Profit, Operating, Gross MarginsCSL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30

More info and screens

7

2. Health

2.1 Basic Checks

CSL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
There is no outstanding debt for CSL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CSL Yearly Shares OutstandingCSL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
CSL Yearly Total Debt VS Total AssetsCSL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

2.2 Solvency

An Altman-Z score of 5.90 indicates that CSL is not in any danger for bankruptcy at the moment.
CSL has a better Altman-Z score (5.90) than 72.50% of its industry peers.
CSL has a debt to FCF ratio of 2.45. This is a good value and a sign of high solvency as CSL would need 2.45 years to pay back of all of its debts.
The Debt to FCF ratio of CSL (2.45) is better than 62.50% of its industry peers.
A Debt/Equity ratio of 0.68 indicates that CSL is somewhat dependend on debt financing.
CSL has a Debt to Equity ratio (0.68) which is comparable to the rest of the industry.
Even though the debt/equity ratio score it not favorable for CSL, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 2.45
Altman-Z 5.9
ROIC/WACC1.6
WACC10.38%
CSL Yearly LT Debt VS Equity VS FCFCSL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

2.3 Liquidity

A Current Ratio of 2.73 indicates that CSL has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.73, CSL is in the better half of the industry, outperforming 72.50% of the companies in the same industry.
A Quick Ratio of 2.29 indicates that CSL has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.29, CSL belongs to the top of the industry, outperforming 82.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.73
Quick Ratio 2.29
CSL Yearly Current Assets VS Current LiabilitesCSL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

More info and screens

4

3. Growth

3.1 Past

CSL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.75%, which is quite impressive.
Measured over the past years, CSL shows a quite strong growth in Earnings Per Share. The EPS has been growing by 19.74% on average per year.
EPS 1Y (TTM)21.75%
EPS 3Y28.43%
EPS 5Y19.74%
EPS Q2Q%7.19%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-0.41%

3.2 Future

Based on estimates for the next years, CSL will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.27% on average per year.
The Revenue is expected to grow by 5.31% on average over the next years.
EPS Next Y13.82%
EPS Next 2Y12.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.64%
Revenue Next 2Y5.31%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CSL Yearly Revenue VS EstimatesCSL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2B 4B 6B
CSL Yearly EPS VS EstimatesCSL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5 10 15 20 25

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 17.37 indicates a rather expensive valuation of CSL.
The rest of the industry has a similar Price/Earnings ratio as CSL.
The average S&P500 Price/Earnings ratio is at 28.47. CSL is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 15.26, the valuation of CSL can be described as correct.
CSL's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 92.74, CSL is valued rather cheaply.
Industry RankSector Rank
PE 17.37
Fwd PE 15.26
CSL Price Earnings VS Forward Price EarningsCSL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

CSL's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, CSL is valued a bit cheaper than the industry average as 62.50% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 17.01
EV/EBITDA 13.35
CSL Per share dataCSL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

CSL's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of CSL may justify a higher PE ratio.
CSL's earnings are expected to grow with 12.27% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.26
PEG (5Y)0.88
EPS Next 2Y12.27%
EPS Next 3YN/A

More info and screens

6

5. Dividend

5.1 Amount

CSL has a Yearly Dividend Yield of 1.05%.
CSL's Dividend Yield is a higher than the industry average which is at 1.07.
Compared to an average S&P500 Dividend Yield of 2.28, CSL's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.05%

5.2 History

The dividend of CSL is nicely growing with an annual growth rate of 15.81%!
CSL has been paying a dividend for at least 10 years, so it has a reliable track record.
CSL has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)15.81%
Div Incr Years34
Div Non Decr Years34
CSL Yearly Dividends per shareCSL Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

12.46% of the earnings are spent on dividend by CSL. This is a low number and sustainable payout ratio.
CSL's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP12.46%
EPS Next 2Y12.27%
EPS Next 3YN/A
CSL Yearly Income VS Free CF VS DividendCSL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B
CSL Dividend Payout.CSL Dividend Payout, showing the Payout Ratio.CSL Dividend Payout.PayoutRetained Earnings

More info and screens

CARLISLE COS INC

NYSE:CSL (2/5/2025, 10:52:08 AM)

351.13

-25.18 (-6.69%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)02-04 2025-02-04/amc
Earnings (Next)N/A N/A
Inst Owners91.63%
Inst Owner Change-0.03%
Ins Owners0.76%
Ins Owner Change1.05%
Market Cap15.92B
Analysts78.33
Price Target482.8 (37.5%)
Short Float %2.25%
Short Ratio2.95
Dividend
Industry RankSector Rank
Dividend Yield 1.05%
Yearly Dividend3.25
Dividend Growth(5Y)15.81%
DP12.46%
Div Incr Years34
Div Non Decr Years34
Ex-Date02-18 2025-02-18 (1)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.95%
Min EPS beat(2)-1.66%
Max EPS beat(2)3.56%
EPS beat(4)3
Avg EPS beat(4)12.21%
Min EPS beat(4)-1.66%
Max EPS beat(4)30.62%
EPS beat(8)6
Avg EPS beat(8)7.78%
EPS beat(12)10
Avg EPS beat(12)13.05%
EPS beat(16)14
Avg EPS beat(16)19.4%
Revenue beat(2)0
Avg Revenue beat(2)-2.52%
Min Revenue beat(2)-4.2%
Max Revenue beat(2)-0.85%
Revenue beat(4)2
Avg Revenue beat(4)1.61%
Min Revenue beat(4)-4.2%
Max Revenue beat(4)9%
Revenue beat(8)2
Avg Revenue beat(8)-0.31%
Revenue beat(12)5
Avg Revenue beat(12)1.73%
Revenue beat(16)8
Avg Revenue beat(16)1.71%
PT rev (1m)1.56%
PT rev (3m)3.52%
EPS NQ rev (1m)0.16%
EPS NQ rev (3m)-2.66%
EPS NY rev (1m)0.04%
EPS NY rev (3m)0.01%
Revenue NQ rev (1m)-0.43%
Revenue NQ rev (3m)-1.27%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)-0.1%
Valuation
Industry RankSector Rank
PE 17.37
Fwd PE 15.26
P/S 3.18
P/FCF 17.01
P/OCF 15.18
P/B 5.76
P/tB N/A
EV/EBITDA 13.35
EPS(TTM)20.21
EY5.76%
EPS(NY)23
Fwd EY6.55%
FCF(TTM)20.65
FCFY5.88%
OCF(TTM)23.13
OCFY6.59%
SpS110.48
BVpS60.95
TBVpS-0.11
PEG (NY)1.26
PEG (5Y)0.88
Profitability
Industry RankSector Rank
ROA 20.87%
ROE 48.93%
ROCE 21.68%
ROIC 16.65%
ROICexc 23.22%
ROICexgc 81.04%
OM 23.42%
PM (TTM) 26.99%
GM 37.98%
FCFM 18.69%
ROA(3y)10.04%
ROA(5y)8.83%
ROE(3y)24.51%
ROE(5y)20.79%
ROIC(3y)12.27%
ROIC(5y)11.04%
ROICexc(3y)13.32%
ROICexc(5y)12.17%
ROICexgc(3y)38.82%
ROICexgc(5y)35.58%
ROCE(3y)15.98%
ROCE(5y)14.38%
ROICexcg growth 3Y7.56%
ROICexcg growth 5Y2.98%
ROICexc growth 3Y19.81%
ROICexc growth 5Y8.88%
OM growth 3Y21.42%
OM growth 5Y13.53%
PM growth 3Y30.48%
PM growth 5Y4.18%
GM growth 3Y8.16%
GM growth 5Y6.32%
F-Score6
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 2.45
Debt/EBITDA 1.41
Cap/Depr 69.51%
Cap/Sales 2.25%
Interest Coverage 250
Cash Conversion 78.56%
Profit Quality 69.24%
Current Ratio 2.73
Quick Ratio 2.29
Altman-Z 5.9
F-Score6
WACC10.38%
ROIC/WACC1.6
Cap/Depr(3y)67.36%
Cap/Depr(5y)57.59%
Cap/Sales(3y)3.33%
Cap/Sales(5y)2.82%
Profit Quality(3y)98.41%
Profit Quality(5y)122.79%
High Growth Momentum
Growth
EPS 1Y (TTM)21.75%
EPS 3Y28.43%
EPS 5Y19.74%
EPS Q2Q%7.19%
EPS Next Y13.82%
EPS Next 2Y12.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-0.41%
Revenue Next Year5.64%
Revenue Next 2Y5.31%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y6.46%
EBIT growth 3Y24.6%
EBIT growth 5Y14.06%
EBIT Next Year40.63%
EBIT Next 3Y17.96%
EBIT Next 5YN/A
FCF growth 1Y70.18%
FCF growth 3Y20.77%
FCF growth 5Y37.12%
OCF growth 1Y44.36%
OCF growth 3Y19.91%
OCF growth 5Y28.78%